Endoscopic retrograde cholangiopancreatography is a radiologic imaging technique, which is performed by combining both endoscopy and fluoroscopy for the treatment of biliary disorders. This technique is majorly utilized for the diagnosis of certain disorders associated with pancreatic ductal systems. Moreover, it assists in the detection of aberrations in the common bile duct, cystic duct, hepatic ducts, and pancreatic ducts. The factors that fuel the growth of the global endoscopic retrograde cholangiopancreatography market are increase in demand for minimally invasive surgeries, rise in focus on the diagnosis of disorders associated with the biliary ducts, and surge in incidence of chronic biliary diseases such as bile duct tumors, jaundice, and others. However, dearth of skilled professionals performing endoscopic retrograde cholangiopancreatography procedure and post-operative complications associated with the treatment restrain the market growth. Conversely, increase in investment by key players in the untapped regions is anticipated to offer lucrative opportunities for the expansion of the market.
The market is segmented on the basis of end user and region. Based on end user, the market is categorized into hospitals, clinics, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players that operate in the market are Johnson & Johnson, Boston Scientific Corporation, Medtronic Plc., CONMED Corporation, Stryker Corporation, Fujifilm Holdings Corporation, Ethicon Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, and Cook Group Incorporated.
- The study provides an in-depth analysis of the global endoscopic retrograde cholangiopancreatography market with current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
- Key players are profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
Endoscopic Retrograde Cholangiopancreatography Market Key Segments:
By End User
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA